c-Rel is a myeloid checkpoint for cancer immunotherapy
- 1 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Cancer
- Vol. 1 (5), 507-517
- https://doi.org/10.1038/s43018-020-0061-3
Abstract
Immunotherapy that targets lymphoid cell checkpoints holds great promise for curing cancer. However, many cancer patients do not respond to this form of therapy. In addition to lymphoid cells, myeloid cells play essential roles in controlling immunity to cancer. Whether myeloid checkpoints exist that can be targeted to treat cancer is not well established. Here we show that c-Rel, a member of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) family, specified the generation of myeloid-derived suppressor cells by selectively turning on protumoral genes while switching off antitumoral genes through a c-Rel enhanceosome. c-Rel deficiency in myeloid cells markedly inhibited cancer growth in mice and pharmaceutical inhibition of c-Rel had the same effect. Combination therapy that blocked both c-Rel and the lymphoid checkpoint protein programmed cell death protein 1 was more effective in treating cancer than blocking either alone. Thus, c-Rel is a myeloid checkpoint that can be targeted for treating cancer.Funding Information
- National Institutes of Health (NIH), USA
This publication has 51 references indexed in Scilit:
- Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancerImmunoTargets and Therapy, 2012
- Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppressionSeminars in Cancer Biology, 2012
- Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung CancerPLOS ONE, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerThe New England Journal of Medicine, 2012
- The Th17 immune response is controlled by the Rel–RORγ–RORγT transcriptional axisThe Journal of Experimental Medicine, 2011
- Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing miceJournal of Leukocyte Biology, 2011
- Role of the NF-κB transcription factor c-Rel in the generation of CD8+ T-cell responses to Toxoplasma gondiiInternational Immunology, 2010
- Development of Foxp3+ Regulatory T Cells Is Driven by the c-Rel EnhanceosomeImmunity, 2009
- REL, encoding a member of the NF-κB family of transcription factors, is a newly defined risk locus for rheumatoid arthritisNature Genetics, 2009
- Transcriptional enhancers: Intelligent enhanceosomes or flexible billboards?Journal of Cellular Biochemistry, 2005